• Reversal of Neuromuscular Blockade- A Discrete Event Simulation Model of Clinical and Operating Room Efficiency Outcomes of Sugammadex Versus Neostigmine In Canada

    Nov 1, 2015, 00:00

  • Cost Reduction For A Health System Through Decreasing Number Of Eligible Patients For Biological Therapy In Patients With Rheumatoid Arthritis Using The Treat To Target Recommendations

    Nov 1, 2015, 00:00

  • Impact of Drug’s Presentation on Patients’ Perception of Treatment’s Risks Benefits Through New Ordinal Gee Modelling Method- Results from Imi Protect Wp6

    Nov 1, 2015, 00:00

  • Diagnosis And Management of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Germany- Results From The Ibis-C Study

    Nov 1, 2015, 00:00

  • A Network Meta-Analysis (NMA) to Assess the Longer-Term Relative Efficacy of Canagliflozin in Patients with Type 2 Diabetes Inadequately Controlled on Metformin

    Nov 1, 2015, 00:00

  • Differential Pricing For Pharmaceuticals- Overview Of A Widely Debated Pricing Concept And Key Challenges

    Nov 1, 2015, 00:00

  • Understanding Key Drivers of Successful Hta Submission — Developing a Model

    Nov 1, 2015, 00:00

  • Comparação De Tratamentos Para Câncer De Cabeça E Pescoço Ajustado Por Escore De Propensão- Radioterapia Versus Cirurgia+Radioterapia

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evicel® Compared With Standard Of Care For Dural Closure In Elective Cranial Surgery- A United Kingdom Hospital Perspective

    Nov 1, 2015, 00:00

  • Assessment of Health Related Quality of Life (Hrql) Using Eq-5d In Type 2 Diabetes Mellitus Patients In A University Teaching Hospital

    Nov 1, 2015, 00:00

  • Impact of The Changes In The Portuguese Pharmacy Remuneration System

    Nov 1, 2015, 00:00

  • The Oxford Participation Activities Questionnaire (Ox-Paq)- Psychometric Analysis

    Nov 1, 2015, 00:00

  • Longitudinal Modeling Of The Relationship Between Lisdexamfetamine Dimesylate And Health-Related Quality Of Life In Adults With Moderate To Severe Binge Eating Disorder

    Nov 1, 2015, 00:00

  • Social Impact of Psoriasis In Spain- A Rasch Analysis From A Survey

    Nov 1, 2015, 00:00

  • Real World Data On Colony-Stimulating Factors (Csf) In Oncology- Patterns Of Use In Brazil

    Nov 1, 2015, 00:00

  • Understanding The Impact Of Patient And Physician Preferences In Personalized Treatment For Melanoma Using A Discrete Choice Experiment

    Nov 1, 2015, 00:00

  • Making Collaborative Relative Effectiveness Assessments Relevant- Experience of 4 Eunethta Pilots Across Pharmaceuticals and Medical Devices

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of One-Piece Drainable Pouch Versus Two-Piece Drainable Pouch For Colostomates Under The Perspective of Patient’s Out-of-Pocket Expenses, In Brazil

    Nov 1, 2015, 00:00

  • The Acceptance Of Morbidity Endpoints In The Amnog Process In Germany- Are There Greater Hurdles For Substances Within Oncology?

    Nov 1, 2015, 00:00

  • Incidencia E Importes Asociados A Las Atenciones Por Hipoglicemia Grave En Pacientes Con Diabetes Mellitus Tipo 2 En Tratamiento Con Antidiabéticos Orales En Ecuador

    Nov 1, 2015, 00:00

  • Costo-Utilidad de Un Esquema Inicial de Tratamiento Con Tofacitinib Comparado Con Terapia Biologica Anti-Tnf en Pacientes Adultos Con Artritis Reumatoide Que Han Presentado Respuesta Inadecuada a Metotrexato en Venezuela

    Nov 1, 2015, 00:00

  • Costing The National Health Insurance Program Prematurity Benefit Package- The Philippine Experience

    Nov 1, 2015, 00:00

  • Burden of Cost in Bronchiolitis Obliterans Syndrome (Bos)- Predictions for the Next Decade

    Nov 1, 2015, 00:00

  • Cost of Familial Mediterranean Fever (Fmf) Disease In Turkey

    Nov 1, 2015, 00:00

  • Estimating the Monetary Value of Relief of Tennis Elbow- A Contingent Valuation Study of Willingness-To-Pay

    Nov 1, 2015, 00:00

  • Economic Burden and Quality of Life of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Germany- Results From The Ibis-C Study

    Nov 1, 2015, 00:00

  • Investigating The Value of Patient Level Data to Inform Estimates of Adpkd Progression Generated Within The Adpkd Outcomes Model

    Nov 1, 2015, 00:00

  • A Cost Comparison of Treatment with Abiraterone Acetate Plus Prednisone in the Pre Chemotherapy Setting Followed By Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration Resistant Pros ...

    Nov 1, 2015, 00:00

  • Economic Burdens of the Top 10 Cancers During 2003-2012 in Taiwan

    Nov 1, 2015, 00:00

  • Evaluation of The Effect of Crude Leaves Extract of Indigofera Spicata Forssk.(Fabaceae) on Blood Glucose Level of Normoglycemic, Oral Glucose Loaded and Alloxan Induced Diabetic Rodents

    Nov 1, 2015, 00:00

  • Development Of An International Observational Study Programme To Describe The Management And Outcomes Of Mild Stroke And Transient Ischaemic Attack In Routine Clinical Practice

    Nov 1, 2015, 00:00

  • Considering Evidence From Health Economics Within Immunization Decision-Making - A Semi Multiple Criteria Decision Approach Using The Decide Tool

    Nov 1, 2015, 00:00

  • The Budget Impact of Orphan Drugs In The Us and Canada- A 2007-2013 Midas Sales Data Analysis

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Tripliam For The Treatment Of Hypertension In Italy

    Nov 1, 2015, 00:00

  • Determinants of Orphan Drug Prices in Fran Regression Analysis

    Nov 1, 2015, 00:00

  • Network Meta-Analysis to Assess Comparative Effectiveness of Beta-Blockers in Patients with Heart Failure and Reduced Ejection Fraction

    Nov 1, 2015, 00:00

  • The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta

    Nov 1, 2015, 00:00

  • Evaluacion economica de tres terapias para la enfermedad pulmonar obstructiva cronica en chile. Análisis de costo utilidad

    Nov 1, 2015, 00:00

  • A Concept For Best-Practice In Therapeutic Drug Monitoring (Tdm) For Kidney Transplant (K-Tx)- Results From Q-Perior Study

    Nov 1, 2015, 00:00

  • Dynamics of Public Outpatient Drug Expenditures in Austria, 2005-2015

    Nov 1, 2015, 00:00

  • Evaluation of Inhaler Technique Mastery and Handling Errors With Spiromax®, Easyhaler®, And Turbuhaler® Devices (Finhaler)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness and Cost-Utility Analyses Comparing Strategies for Initial Treatment of Rheumatoid Arthritis Using Published Outcomes- Economic Lessons From The Tear Trial

    Nov 1, 2015, 00:00

  • Costo-Efectividad De Toracotomía Versus Videotoracoscopia En Pacientes Con Cáncer De Pulmón De Célula No Pequeña En Estadio I

    Nov 1, 2015, 00:00

  • Introduction of Formal Risk Sharing Agreements (Rsa)- A Promising Solution for Sustainable and Predictable Pharmaceutical Expenditures In Bulgaria

    Nov 1, 2015, 00:00

  • Assessment of Iron Deficiency And Anemia In Pregnant Women In Fran An Observational Study

    Nov 1, 2015, 00:00

  • The Economics Of Critical Care Diagnostics- The Case Of Procalcitonin-Guided Care In Treatment Of Acute Respiratory Infection In The U.S

    Nov 1, 2015, 00:00

  • Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Pr ...

    Nov 1, 2015, 00:00

  • Adherence to Antiretroviral Therapy Among Patients Lost-To-Follow Up- A Case of An Hiv Clinic in a Private-For-Profit Health Facility in Kampala, Uganda

    Nov 1, 2015, 00:00

  • Evaluating Diabetes Patients’ Preferences for Profiles of Glp-1 Treatments In The United Kingdom- A Discrete Choice Experiment

    Nov 1, 2015, 00:00

  • Indicação Do Medicamento Talidomida Para O Tratamento De Mieloma Múltiplo- Uma Avaliação Para Atualização Da Rename

    Nov 1, 2015, 00:00

  • Quantitative Assessment of Canadian Provincial Public Funding Decisions for Oncology Drugs Following Pcodr Economic Evaluations for 2013 and 2014

    Nov 1, 2015, 00:00

  • U.s. Payer Expectations for Reimbursement of Biosimilars

    Nov 1, 2015, 00:00

  • Correlation Between Equation For Estimating Glomerular Filtration Rate- Chronic Kidney Disease Epidemiology Collaboration -Ckd -Epi, Cockcroft-Gault -Cg- And Modification Of Diet And Renal Disease –Mdrd4- In Colombia

    Nov 1, 2015, 00:00

  • Systematic Literature Review of the Burden of Illness in Hypertriglyceridemia

    Nov 1, 2015, 00:00

  • The Effect of Szigetvár Thermal Water on Quality of Life of Patients With Rheumatic Diseases

    Nov 1, 2015, 00:00

  • Generic Drugs Adoption In Turkish Healthcare System

    Nov 1, 2015, 00:00

  • Do Free Medications Improve Observance Among Diabetic Patients?

    Nov 1, 2015, 00:00

  • Systematic Review and Cost-Effectiveness Analysis of Drug Used in Obesity Treatment in Brazil, Under Health System Perspective

    Nov 1, 2015, 00:00

  • Health Related Quality of Life (Hrqol) In Patients Who Have Undergone Colectomy for Ulcerative Colitis- Impacts of Complications Post-Surgery

    Nov 1, 2015, 00:00

  • Early Economic Evaluation of A Hypothetical Perfect Test for Predicting The Effectiveness of Implantable Pacemaker-Defibrillator Devices (Crt-D) In Patients With Heart Failure

    Nov 1, 2015, 00:00

  • Antibiotic Prescription Practices of Pediatricians In Hospital Care In Cyprus

    Nov 1, 2015, 00:00

  • Aretaeus- Retrospective Study Of Medication Usage Patterns Following The Diagnosis Of Type 2 Diabetes In Latin America

    Nov 1, 2015, 00:00

  • French Physician Sensitivity To And Consideration Of The Costs Of Cancer Treatment

    Nov 1, 2015, 00:00

  • A One-Year Follow-Up of Patients with Acute Coronary Syndrome (Acs) and Diabetes Treated with Statins- Outcomes and Health Care Costs Supported by Italian National Health Service

    Nov 1, 2015, 00:00

  • Is Assignment of Financial Value Stimulating French Researchers of Paris Academic Hospitals to Publish in International Journals? Results of the Diazepam Survey

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Afatinib As 1st-Line Treatment Of Metastatic Non-Small Cell Lung Cancer With Del19 Mutation Of Egfr Gene

    Nov 1, 2015, 00:00

  • Impact of Genetic Factors on Gastrointestinal Bleeding in a Prospective Cohort of new Warfarin users

    Nov 1, 2015, 00:00

  • Evaluación Del Costo-Efectividad Y Costo-Utilidad Del Uso De Rivaroxabán En Pacientes Con Fibrilación Auricular No Valvular Frente A Warfarina En El Contexto Ecuatoriano

    Nov 1, 2015, 00:00

  • Avaliação Do Impacto Econômico De Afastamentos Laborais Por Câncer De Mama . Análise Preliminar Singular Institucional

    Nov 1, 2015, 00:00

  • Sofosbuvir- The Failure of Pricing Policies In The European Union

    Nov 1, 2015, 00:00

  • How to Institutionalize The “Knowledge to Action” Framework for Health Technology Assessment?

    Nov 1, 2015, 00:00

  • The Impact Of First-Line Tyrosine Kinase Inhibitors (Tkis) On Overall Survival In Patients With Advanced Non-Small Cell Lung Cancer (Nsclc) And Activating Epidermal Growth Factor Receptor (Egfr) Mutations- Meta-Analysis Of Major Randomized ...

    Nov 1, 2015, 00:00

  • The Cost of Radiotherapy- What Do We Know? a Systematic Search of the Literature Between 1981 and 2015

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life of People From Low-Income Families In Hong Kong, China

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for the First-Line Treatment of Mantle Cell Lymphoma not Eligible for Stem Cell Transplantation- a Scottish Perspective

    Nov 1, 2015, 00:00

  • Healthcare Associated Infections. Impact And Costs Of Diagnosis And Management Of Clostridium Difficile Infections (Cdi). The Experience Of A University Hospital In Rome

    Nov 1, 2015, 00:00

  • Subcutaneous Vs Intravenous Administration Of Trastuzumab In Her2+ Breast Cancer Patients- A Macedonian Cost-Minimization Analysis

    Nov 1, 2015, 00:00

  • The Impact of Increasing Multiple Sclerosis (Ms) Severity Level on Employment and Caregiver Burden

    Nov 1, 2015, 00:00

  • How are Pain Treatment Response Rates In Primary Care Influenced By Co-Prescription of Cyp2d6 Inhibitors?

    Nov 1, 2015, 00:00

  • Quality Of Life And Emotional Impact Of A Fixed Dose Combination Of Antihypertensive Drugs In Patients With Uncontrolled Hypertension

    Nov 1, 2015, 00:00

  • Real-World Data on Multiple Comorbidities Among Patients With Hepatitis C- Considerations for Patient Care And Prognosis

    Nov 1, 2015, 00:00

  • A Systematic Review Of Cardiovascular Event Utilities In Europe

    Nov 1, 2015, 00:00

  • Structure Of Health-Related Direct Costs In Ukraine - The First Step Of Analysis

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Fibrin Sealant Patch- A Proposal To Assess The Economic Value In Hemostasis And As A Surgical Sealant

    Nov 1, 2015, 00:00

  • Experiences with Price Competition of Biosimilar Drugs In Hungary in Case of Colony-Stimulating Factor Products

    Nov 1, 2015, 00:00

  • Challenges In Translating The Multiple Sclerosis International Quality of Life (Musiqol) Questionnaire In 57 Languages

    Nov 1, 2015, 00:00

  • Extension of Indication With Mature Products- Toward More Incentives Rewarding Innovation?

    Nov 1, 2015, 00:00

  • Regispt- Registry of Registries In Portugal

    Nov 1, 2015, 00:00

  • The South African Guidelines for Pharmacoeconomic Submissions- A Review In Context of Existing Legislation and Challenges to Implementation

    Nov 1, 2015, 00:00

  • Analysis of Four Early Dialogues (ED) as Part of the Seed (Shaping European Early Dialogues) Pilot- Lessons Learnt and Way Forward. Sanofi’s Perspective

    Nov 1, 2015, 00:00

  • Towards Creating A National System of Care for Patients With Orphan Diseases

    Nov 1, 2015, 00:00

  • Assessing The Treatment Burden for Growth Hormone Deficiency (Ghd) In Children- Concept Elicitation Results Supporting The Development of The Treatment Burden Measure for Childhood Ghd (Tb-Cghd)

    Nov 1, 2015, 00:00

  • Indirect Comparison for E/C/F/Taf In Treatment Naïve Hiv Patients

    Nov 1, 2015, 00:00

  • The Analyze of Consumption of Fixed Combinations of Drugs in Therapy of Hypertension

    Nov 1, 2015, 00:00

  • Analysis of Eribulin Mesylate Utilzation in Patients with Metastatic Breast Cancer (Mbc) by Line of Therapy and Associated Changes Over Time

    Nov 1, 2015, 00:00

  • Quality Of Life In Patients With Breast Cancer In Slovakia

    Nov 1, 2015, 00:00

  • External And Internal Reference Pricing As Cost Containment Measures In Bulgaria

    Nov 1, 2015, 00:00

  • Psychometric Validation of the New International Questionnaire to Assess Health-Related Quality of Life (Hrql) Specific to Viral Hepatitis C- Proqol-Hcv

    Nov 1, 2015, 00:00

  • Empirical Evidence for Identifying Best Practices in Translatability Assessment as a Proactive Tool for Enhancing the Quality of Pro and Hrqol Translation and Linguistic Validation

    Nov 1, 2015, 00:00

  • Recent Trends In Anaphylaxis-Related Hospitalization In The United States

    Nov 1, 2015, 00:00

  • Thrombectomy in the treatment of acute ischemic stroke- what effects do methodological differences in trial design have on comparability of outcomes?

    Nov 1, 2015, 00:00

  • Impact of Overweight and Obesity in the Frequency Medical Complications During Pregnancy and Economic Burden in the High Risk Pregnancy in Mexico

    Nov 1, 2015, 00:00

  • Cost of Achieving Combined Improvements in HbA1c and Weight without Hypoglycaemia over 4 Years in a Post-Hoc Analysis of Dapagliflozin + MET Vs Glipizide + MET

    Nov 1, 2015, 00:00

  • Innovative Methods For Early Diagnostic Of Cancer

    Nov 1, 2015, 00:00

  • Review of Adherence Measures for use in Phase Iv Studies and Recommendations for a new Standardized Generic Measure

    Nov 1, 2015, 00:00

  • Evaluation Of Patient-Centered Care In Short-Term Cancer Survivors, Through The Patient Assessment Of Chronic Illness Care Questionnaire

    Nov 1, 2015, 00:00

  • Aspirin Versus Clopidogrel in Patients with Acute Myocardial Infarction- a Cost and Effectiveness Comparison from Beijing Medical Insurance Database

    Nov 1, 2015, 00:00

  • Comparison Of Different Costing Methods

    Nov 1, 2015, 00:00

  • Rapid and Automated Test for Connectedness of Evidence Networks in Network Meta Analysis

    Nov 1, 2015, 00:00

  • Cost Analysis of Residual Viremia Detected by Two Real-Time Pcr Assays For Response-Guided (Dual Or Triple) Therapy of Hcv Genotype 1 Infection

    Nov 1, 2015, 00:00

  • Prevalence And Risk Factors Of Skin Cancer In Mexico- An Observational Study

    Nov 1, 2015, 00:00

  • Short And Long-Term Economic Impact of Secondary Hyperparathyroidism Treatment in Chronic Kidney Disease in Carlos Andrade Marin Hospital (Ecuador)

    Nov 1, 2015, 00:00

  • Rectal Culture Testing Before Transrectal Ultrasound-Guided Prostate Biopsy (Trusbx) In Hong Kong – A Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • The Cost-of-Disease of Metastatic/Inoperable Gastrointestnal Stromal Tumors in Turkey- an Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Delayed-Release Dimethylfumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00

  • Trends of Hpv Vaccine Uptake, Completion, and Adherence in the United States- 2006-2011

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Bortizomib For Multiple Myeloma- A Systematic Review

    Nov 1, 2015, 00:00

  • Adaptive Pathways May Expand The Gap Between Regulators And Payers

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Spain

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Wet Age-Related Macular Degeneration (Wamd) In Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • The Increasing Cost Burden of Obesity Related Cancer to Nhs England

    Nov 1, 2015, 00:00

  • Differences In Work Productivity Activity Imparment In Rrms Patients Initiated on Oral Dmf or Platform Therapies In Europe and Us

    Nov 1, 2015, 00:00

  • The Effect Of Metformin Use And Mortality Among Those With Pancreatic Cancer And Type 2 Diabetes Mellitus- Findings From A Nationwide Population Retrospective Cohort Study

    Nov 1, 2015, 00:00

  • Analysis of Direct Costs Associated With Cystic Fibrosis In Single Center In Slovakia- 5 Years Review

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Sunitinib As Second-Line Treatment For Gastrointestinal Stromal Tumor(Gist) In China

    Nov 1, 2015, 00:00

  • Applying Symptom-Based Utility Functions in Health Economic Modelling- A Case Study of Uterine Fibroids

    Nov 1, 2015, 00:00

  • The Economic Aspect Of Warfarin Pharmacogenetics Introduction Into Health System

    Nov 1, 2015, 00:00

  • Hospitalization Expenses Analysis Of Chinese Stroke Patients With Urban Employee Basic Medical Insurance

    Nov 1, 2015, 00:00

  • Resource Utilization Among Advanced Squamous and non-Squamous non-Small Cell Lung Cancer Patients Receiving Second-Line Treatment in France, Germany, Italy, and Spain- Results of A Retrospective Medical Chart Review

    Nov 1, 2015, 00:00

  • Clinical Evaluation of Amritadi Guggulu and Mandoora Bhasma In Osteoarthritis Patients

    Nov 1, 2015, 00:00

  • Closing the Gap Between Hta and Innovation Uptake in Finnish Hospitals

    Nov 1, 2015, 00:00

  • Impact of Adherence to Oral Antidiabetics on All-Cause Mortality- A Population Based Study

    Nov 1, 2015, 00:00

  • Does Use Of Antipsychotics Increase The Risk Of Death- A Systematic Review And Meta-Analysis Of Observational Studies

    Nov 1, 2015, 00:00

  • Economic Evaluations Of New Oral Anticoagulants For The Prevention Of Venous Thromboembolism After Total Hip Or Total Knee Replacement

    Nov 1, 2015, 00:00

  • Adding Bevacizumab To Single-Agent Chemotherapy For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer- A Cost-Effectiveness Analysis Of The Aurelia Trial

    Nov 1, 2015, 00:00

  • Healthcare Expenditure On Prevention In The Spending Review Era

    Nov 1, 2015, 00:00

  • Development and Validation of A Conceptual Model of Multiple Myeloma

    Nov 1, 2015, 00:00

  • Hospitalizations In Hyperchylomicronemia Patients In Quebec, Canada; Results From A Real-World Observational Study

    Nov 1, 2015, 00:00

  • Surgery As An Outcome In Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Capturing Accurate Concomittant Medications Information in Global Trials

    Nov 1, 2015, 00:00

  • An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps)- Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases

    Nov 1, 2015, 00:00

  • Costs of Inflamatory Bowel Disease (Crohns Disease and Ulcerative Colitis) In Serbia

    Nov 1, 2015, 00:00

  • Do Clinical Guideline Implementations Reduce The Government Budget? A Clinical Guideline-Based Budget Impact Model In Reimbursement Of Inhaler Treatments In Copd

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Edoxaban Compared With Other Licensed Noacs For The Prevention Of Stroke And Systemic Embolic Events In The Uk

    Nov 1, 2015, 00:00

  • Patient-Reported Outcomes in Studies Published in 2014- Which Disease Areas Have Been the Main Focus of Clinical Research?

    Nov 1, 2015, 00:00

  • Cost-Minimization Analysis and Total Cost Analysis for A Weight Range In Crohn’s Disease Treatment With Anti-Tnf Biologics Under Brazilian Private Health Care System Perspective

    Nov 1, 2015, 00:00

  • To What Extent Do Payers’ Assessment Of Clinically Relevant Outcomes Align With Clinicians In Oncology?

    Nov 1, 2015, 00:00

  • Comparison of Regulatory Labels And Hta Decisions for Chronic Hepatitis-C Therapies

    Nov 1, 2015, 00:00

  • A Systematic Comparision of Iqwig Recommendations and G-Ba Decisions In The Amnog Process In Germany

    Nov 1, 2015, 00:00

  • Network Meta-Analysis of Survival Data Using Fractional Polynomials – an Example with First Line Metastatic Renal cell cancer Treatments

    Nov 1, 2015, 00:00

  • Study Of Knowledge, Attitude And Practice Of General Population Of Guntur Towards Silent Killer Diseases - Hypertension And Diabetes

    Nov 1, 2015, 00:00

  • Análisis De Costo-Utilidad De Pcv13 Versus Ppsv23 En Adultos De 65 Años Y Más

    Nov 1, 2015, 00:00

  • Evaluation Of ‘Real-World’ Ipilimumab Data In Ireland

    Nov 1, 2015, 00:00

  • Prefmab- Final Analysis Of Patient Satisfaction With Subcutaneous Versus Intravenous Rituximab In Previously Untreated Cd20+ Diffuse Large B-Cell Lymphoma Or Follicular Lymphoma

    Nov 1, 2015, 00:00

  • Cost of Illness Study of Type 2 Diabetes Mellitus in the Newly Established Diabetology Outpatient Facility in the Czech Republic

    Nov 1, 2015, 00:00

  • Fda Breakthrough Medicines; Have They Caused Breakthrough Headaches for Hta Agencies?

    Nov 1, 2015, 00:00

  • Nocturia Work Productivity And Activity Impairment Compared To Other Common Chronic Diseases- A Systematic Review

    Nov 1, 2015, 00:00

  • Improving The System of Healthcare Provision for Patients With Hypothyroidism In Ukraine

    Nov 1, 2015, 00:00

  • Prevalence Of Switching From Brand To Generic Asthma Medications

    Nov 1, 2015, 00:00

  • Avoidable Burden and Unmet Need Associated with Non-Radiographic Axial Spondyloarthritis Treatment- A Cross-Sectional European Study in the Real World Setting

    Nov 1, 2015, 00:00

  • Assessing Pharmaceuticals with Limited Evidence in Germany – Current Experience

    Nov 1, 2015, 00:00

  • Prevalence of Hepatitis C And Presence of Comorbidities In Sweden- A Nationwide Population-Based Register Study

    Nov 1, 2015, 00:00

  • Number of Osteoporosis Patients with Pathological Fractures by Months in Outpatient Care in the Light of Physiotherapy Care in Hungary

    Nov 1, 2015, 00:00

  • Increased Cost-Effectiveness Of Diagnostic Imaging In Patients With Suspected Cad By Using A New Clinical-Biohumoral Predictive Model Of Disease

    Nov 1, 2015, 00:00

  • Oral Vinorelbine Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-Line Treatment for Patients with Advanced non- Squamous non- Small Cell Lung Cancer- a Cost Minimization Analysis in Twelve European Countries

    Nov 1, 2015, 00:00

  • Estimating The Cost-Effectiveness Profile Of A Vaccination Programme With A Nine-Valent Hpv Vaccine In Italy

    Nov 1, 2015, 00:00

  • Colonrectal Cancer Evaluation Of Italian Screening And Mortality

    Nov 1, 2015, 00:00

  • COST-EFFECTIVENESS ANALYSIS ON STARTING PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB

    Nov 1, 2015, 00:00

  • Estimating Eortc-8d Health State Utility Values From Eortc Qlq-C30 Scores In Relapsed Multiple Myeloma

    Nov 1, 2015, 00:00

  • Cost-Minimization Analysis Of Rivaroxaban In Comparison To Enoxaparin Plus Warfarin For The Treatment Of Venous Thromboembolism (Vte) Under The Private Healthcare System Perspective

    Nov 1, 2015, 00:00

  • Analysis Of Breast Cancer Patients’ Clinical Pathway Being Diagnosed By Mammography Breast Screening Program

    Nov 1, 2015, 00:00

  • Do Clinical Guidelines for Hernia Surgery Reduce Costs and Improve Patient Outcomes, and Do Surgeons Follow Them?

    Nov 1, 2015, 00:00

  • Uso De Recursos Medicos En La Intervencion De Examenes De Tamizaje Y Tratamiento De Pacientes Con Problemas Y Trastornos De Salud Mental 2012-2013

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of Novel Oral Anticoagulants For Acute Treatment And Secondary Prevention Of Venous Thromboembolic Disease

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Pembrolizumab for Unresectable Metastatic Melanoma After Progression with Ipilimumab in England

    Nov 1, 2015, 00:00

  • Health Related Quality Of Life In Tb Patients Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Costo De Cáncer De Mama En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Impacto Económico Del Uso De Vismodegib En El Tratamiento De Pacientes Con Carcinoma Basocelular Localmente Avanzado En Venezuela

    Nov 1, 2015, 00:00

  • Adapalene 0.1% / Benzoyl Peroxide 2.5% + Doxycycline 200mg Is A Less Expensive Alternative Compared to Oral Isotretinoin for The Management of Severe Nodular Acne In Sweden

    Nov 1, 2015, 00:00

  • Real-World Analysis Of Tyrosin Kinase Inhibitor Treatemnt Patterns Among Patients With Chronic Myeloid Leukemia In Korea

    Nov 1, 2015, 00:00

  • Comparative Effectiveness on Cardiovascular Outcomes of Metformin Initial Therapy and Add-on Second-Line Drugs Among Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Treatment of Macular Edema- What’s New? Evidence From An Hta Study Comparing Ranibizumab And Dexamethasone Implant

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Health-Related Quality of Life In Patients Receiving Parenteral Nutrition

    Nov 1, 2015, 00:00

  • Is Nice Too Optimistic About Savings From Faecal Calprotectin Testing?

    Nov 1, 2015, 00:00

  • Drug Utilisation And Healthcare Resources Use In Patients With Psoriatic Arthritis And Psoriasis

    Nov 1, 2015, 00:00

  • The Clinical and Economic Burden of Medication Errors In The Canadian Acute Care Setting- A Review of Published Studies

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Individually Vs Vial-Packaged Strips For Glucose Monitoring

    Nov 1, 2015, 00:00

  • Racial Disparities In total ankle arthroplasty Utilization and outcomes

    Nov 1, 2015, 00:00

  • Economic Analysis Of Cost Of Drug Treatment Involved In The Maintainance Therapy Of Copd

    Nov 1, 2015, 00:00

  • Retrospective Comparison Of Real-Life Survival Data From Single Centre Trials - The Clinical Outcome Of Vemurafenib Therapy In Metastatic Melanoma Patients

    Nov 1, 2015, 00:00

  • Economic Burden of Chronic Spontaneous Urticaria And Psoriasis- Patients Perspective From Europe

    Nov 1, 2015, 00:00

  • Advanced Therapy Medicinal Products May Dramatically Impact Payers’ Budget

    Nov 1, 2015, 00:00

  • A Literature Study About Utilization of Oriental Medical Services

    Nov 1, 2015, 00:00

  • Evaluation Of Patterns Of Care In Renal Cell Carcinoma (Rcc)- High Unmet Need Persists

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Sofosbuvir and Ledipasvir In The Treatment of Patients With Hepatitis C

    Nov 1, 2015, 00:00

  • Compliance with the Recently Introduced System of Generic Substitution and Reference Pricing in Ireland; Implications for Further Policy Rollout

    Nov 1, 2015, 00:00

  • Objective Data In Parkinson’s Disease Therapy Management – A Retrospective Analysis Of The Parkinson’s Kinetigraph (Pkg) Database

    Nov 1, 2015, 00:00

  • Real-World Evidence of Iron Chelation Therapy In Transfusion-Dependent Mds Patients- A Portuguese Hospital Registry

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Panitumumab + Folfox Compared To Cetuximab + Folfiri As First-Line Treatment For Patients With Wild-Type (Wt) Ras (Exons 2, 3, And 4 Of Kras And Nras) Metastatic Colorectal Cancer (Mcrc) In Colombia

    Nov 1, 2015, 00:00

  • Subjective Outcomes With Bone Conduction and Middle Ear Implants for Patients Wth Conductive or Mixed Hearing Loss

    Nov 1, 2015, 00:00

  • Cost Distribution Analysis Related to the Use of Tyrisine-Kinase Inhibitors (Tki) and the Combination of Pemetrexed/Cisplatin in the Treatment of Non-Small Cell Lung Cancer (Nsclc) Locally Advanced or Metastatic in Presence of Epidermal Gro ...

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain

    Nov 1, 2015, 00:00

  • A Systematic Literature Review to Assess the Impact of Social Networks on Healthcare in India

    Nov 1, 2015, 00:00

  • Costs Of Septic Shock In England, Wales And Northern Ireland In 2012

    Nov 1, 2015, 00:00

  • Implicaç’es Entre os Gastos Com a Produção Ambulatorial em Média Complexidade E À Atenção Básica

    Nov 1, 2015, 00:00

  • Analysis of the Relationship Between Patient-Reported Outcomes (Pros) and Clinical Outcomes In Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients without Prior Chemotherapy

    Nov 1, 2015, 00:00

  • Critical Appraisal Of Real World Evidence – A Review Of Recommended And Commonly Used Tools

    Nov 1, 2015, 00:00

  • Comparative Effectiveness and Cost-Effectiveness of Generic Alendronate, Risendronate, Denosumab and Zolendronic Acid for Secondary Prevention of Fragility Fractures - Perliminay Results

    Nov 1, 2015, 00:00

  • The Use Of Social Media To Generate Health Data For Effectiveness Research- A Scoping Review

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis Of Chocolate Consumption For Prevention Of Cardiometabolic Disease

    Nov 1, 2015, 00:00

  • Breast Cancer in Brazil- Hospitalization Costs

    Nov 1, 2015, 00:00

  • Characteristics of Patients Starting Biologic Treatments for Rheumatoid Arthritis in The Real World- Systematic Review

    Nov 1, 2015, 00:00

  • Applying Weighted Cumulative Exposure Models to Patterns of Nonspecific Symptom Consultations for Early Diagnosis- A Primary Care Database Study of Knee Pain and Osteoarthritis

    Nov 1, 2015, 00:00

  • The Cost Of Treatment Of The New Antiviral Therapies Against The Hepatitis C Virus

    Nov 1, 2015, 00:00

  • Telemedicine Compared With Standard Care In Type 2 diabetes mellitus. A randomized Controlled Project In An Outpatient Clinic

    Nov 1, 2015, 00:00

  • Hospital Costs Of Contrast-Induced Nephropathy

    Nov 1, 2015, 00:00

  • Evolution Influence of HTA in Emerging Markets

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Formoterol Easyhaler In The Treatment Of Asthma In Children In The Russian Federation

    Nov 1, 2015, 00:00

  • Economic Evaluation of Tocilizumab Monotherapy Vs Adalimumab Monotherapy In Patients With Rheumatoid Arthritis In Italy

    Nov 1, 2015, 00:00

  • Healthcare Resource Utilization Costs Related to Anaemia Management In Chronic Kidney Disease Non-Dialysed Patients- A Retrospective Clinical and Administrative Database Analysis

    Nov 1, 2015, 00:00

  • Rituximab Sc Vs Rituximab Iv for non-Hodgkin’s Lymphomas (Nhls)- an Economic Evaluation for the Greek Healthcare System

    Nov 1, 2015, 00:00

  • Cost Effectiveness Analysis of Aripiprazole Once-Monthly Versus Paliperidone Palmitate in Spain

    Nov 1, 2015, 00:00

  • Trends In Emergency Room Visits Due To Hyperkalemia In The United States

    Nov 1, 2015, 00:00

  • The Ceesp Economic Evaluation- Can Clinical Efficacy and Cost-Effectiveness Co-Exist in France

    Nov 1, 2015, 00:00

  • Treatment Costs In Primary And Secondary Healthcare In Finland

    Nov 1, 2015, 00:00

  • Coping With Discrepancies In Epidemiological Data From Various Sources For Low-Incidence Diseases- The Case Of Multidrug-Resistant Tuberculosis In Germany

    Nov 1, 2015, 00:00

  • The Impact of Severe Asthma on the Quality of Life- a Systematc Review

    Nov 1, 2015, 00:00

  • Cost Analysis Study of Anti-Diabetic Fixed Dose Combination Drugs- An Indian Scenario

    Nov 1, 2015, 00:00

  • Nordic Longitudinal Data from Electronic Medical Records and Full Population National Registers- Unique Opportunities for New Insights in Benefit of Diabetes Patients

    Nov 1, 2015, 00:00

  • Treatment Patterns and Characteristics of Medicare Beneficiaries with Hiv Related Cachexia

    Nov 1, 2015, 00:00

  • Cost-Utility of Ranibizumab Versus Aflibercept for Treating Visual Impairment Due to Diabetic Macular Edema In Greece

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of N-Terminal Pro-B-Type Natriuretic Peptide Testing For The Diagnosis And Prognosis Of Heart Failure In Greece

    Nov 1, 2015, 00:00

  • 18th Euro Abstracts - Financial Disclosure Statement

    Nov 1, 2015, 00:00

  • Comparison of Economic Evaluation Between Three Major HTA Agencies. Is There a French Touch?

    Nov 1, 2015, 00:00

  • The Efficacy and Safety of Abatacept, Adalimumab, Etanercept And Tocilizumab are Comparable In Polyarticular Juvenile Idiopathic Arthritis

    Nov 1, 2015, 00:00

  • Health Care Cost and Utilization Associated With Alpha-1 Antitrypsin Deficiency Among A Cohort of Medicare Beneficiaries With Copd

    Nov 1, 2015, 00:00

  • Cultural Adaptation Into Spanish (Spain) of the Questionnaire “Overactive Bladder - Family Impact Measure (Oab-Fim)”

    Nov 1, 2015, 00:00

  • Burden Of Infantile Hemangioma On Family- An International Cross-Sectional Study

    Nov 1, 2015, 00:00

  • Effects of Financial Incentives for Saving Drug Expenditures on Physician Prescription Behaviors

    Nov 1, 2015, 00:00

  • Do evidence review groups bias nice decisions?

    Nov 1, 2015, 00:00

  • Examination of Knowledge About Hpv Infection Among Mothers and Daughters

    Nov 1, 2015, 00:00

  • Biosimilars Entry And Price Development In Europe

    Nov 1, 2015, 00:00

  • Value Assessment for Genetic Testing of Drug Variation In An Elderly Population

    Nov 1, 2015, 00:00

  • Observational Study of Resource use and Cost of Alzheimer’s Disease in Europe (Geras) - 18-Month Results from the French Cohort

    Nov 1, 2015, 00:00

  • Potentially inadequate Medication (Pim) Effects on Adverse Drug Events (Ades) and Costs- Hospital Universitario Austral (Hua)

    Nov 1, 2015, 00:00

  • Cost of Reaching Defined HbA1c Target Using Canagliflozin Compared to Dapagliflozin as Add-On to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) in the United Arab Emirates (UAE)

    Nov 1, 2015, 00:00

  • The Impact Of Pharmaceutical Innovation On Premature Cancer Mortality In Portugal

    Nov 1, 2015, 00:00

  • Subject Recommendations for Improving Their Compliance and Engagement in Completing Daily Electronic Diaries in Osteoarthritis Clinical Trials

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Conjugate Pneumococcal Vaccination In Croatia

    Nov 1, 2015, 00:00

  • Impact of a Pharmacotherapeutic Follow-Up Program on the Cost-Month-Patient, Stratified By Risk-Pharmacological Type

    Nov 1, 2015, 00:00

  • Analysis of Cost Minimization of Adalimumab Compared With Infliximab for The Treatment of Ulcerative Colitis In The Public Market In Mexico

    Nov 1, 2015, 00:00

  • Cost of Cervical Cancer and Cervical Intraepithelial Neoplasia in Croatia

    Nov 1, 2015, 00:00

  • Nice Patient Access Schemes – A Who, What, Why, When and How

    Nov 1, 2015, 00:00

  • The Use and Acceptance of Meta-Analysis of Survival Outcomes to Support Health Technology Assessment Submissions in the Uk

    Nov 1, 2015, 00:00

  • Modeling The Cost-Effectiveness of The All Oral, Direct-Acting Antiviral Regimen Daclatasvir Plus Sofosbuvir In Patients Co-Infected With Hepatitis C Virus (Hcv) And Hiv

    Nov 1, 2015, 00:00

  • Effects of Nutritional Supplement Usage on Mortality In Patient Underwent Abdominal Resection Surgery for Non-Oncological Conditions

    Nov 1, 2015, 00:00

  • Cost Study of Assisted Reproductive Technologies in Ukraine

    Nov 1, 2015, 00:00

  • A Systematic Review of The Humanistic Burden of Disease In Patients With Fabry Disease

    Nov 1, 2015, 00:00

  • Analisis De Costo-Efectividad De La Educacion De Pacientes Con Diabetes Tipo 2 Por Pares

    Nov 1, 2015, 00:00

  • Ultra Orphan and Cancer Drug Pricing Trends In The Us and The Uk

    Nov 1, 2015, 00:00

  • A Handbook and a Toolkit for Hospital-Based Health Technology Assessment

    Nov 1, 2015, 00:00

  • An Analysis of German Amnog Re-View Assessments and Learnings for Manufacturers

    Nov 1, 2015, 00:00

  • COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS

    Nov 1, 2015, 00:00

  • Review Of Us Medicare System For Reimbursement Of New Medical Devices

    Nov 1, 2015, 00:00

  • Gasto de Bolsillo y Gasto Catastrófico en Salud en Hogares de Cartagena de Indias, Colombia

    Nov 1, 2015, 00:00

  • Economic Evaluation of Saxagliptin in Combination with Metformin Versus Sitagliptin or Vildagliptin in Combination with Metformin in Patients with Type 2 Diabetes in Russia

    Nov 1, 2015, 00:00

  • How Pharmaceutical Cost Indicators Are Affected When Adjusted To Hospitals’ Clinical Workload- Data Analysis For Greek Nhs Hospitals

    Nov 1, 2015, 00:00

  • Cholic Acid Decreases the Distribution Coefficient of Simvastastin- A Potential for Increasing Simvastatin Bioavailability

    Nov 1, 2015, 00:00

  • Economic Evaluation For Fluvestrant 500 Mg Im Versus Exemestene In Egyptian Patients With Metastatic Breast Cancer

    Nov 1, 2015, 00:00

  • Cardiovascular Outcomes of Antidiabetic Therapy - Results of a Literature Search

    Nov 1, 2015, 00:00

  • Evaluation of The Burden of Parkinson’s Disease In Medicare And Linked Long Term Care Population

    Nov 1, 2015, 00:00

  • Diálise Planejada E A Utilização Regular Da Atenção Primária À Saúde Entre Os Pacientes Diabéticos Do Município De Belo Horizonte, Minas Gerais, Brasil

    Nov 1, 2015, 00:00

  • Real-World Data And Budget Impact Analysis for Incobotulinum Toxin A and Onabotulinum Toxin A for Upper Limb Post-Stroke Spasticity At A Uk Centre

    Nov 1, 2015, 00:00

  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States

    Nov 1, 2015, 00:00

  • Perfil Alimentario Según Estado Nutricional De Estudiantes Universitarios De Valparaiso, Chile

    Nov 1, 2015, 00:00

  • Assessment of Drug Use Pattern Using Who Prescribing And Patient Care Indicators In A Referral Hospital In Ethiopia

    Nov 1, 2015, 00:00

  • Translation and Cultural Adaptation Difficulties Encountered During Linguistic Validation of the Habitual Activity Estimation Scale (Haes)

    Nov 1, 2015, 00:00

  • Economic Value of Stemi Program Investment In Sao Paulo, Brazil

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System

    Nov 1, 2015, 00:00

  • Exploratory Analysis of Apac Values Versus Recommended Treatment Guidelines For Metastatic Non-Small Cell Lung Cancer (Mnsclc) In The Brazilian Public Healthcare System

    Nov 1, 2015, 00:00

  • A Systematic Literature Review of Global Economic Evaluations of Rasagiline for Parkinson’s Disease

    Nov 1, 2015, 00:00

  • External Validity of the Well-Being Related to Food Questionnaire (Well-Bfq©)- Variations According to the Subjects’ Nutritional Status

    Nov 1, 2015, 00:00

  • A Study On Cytogenetic And Molecular Analysis Of Presenilin 1 (Ps1) Gene In Alzheimer’s Disease

    Nov 1, 2015, 00:00

  • Correlation of Triglycerides and Acute Pancreatitis- a Systematic Evidence Review

    Nov 1, 2015, 00:00

  • Non-Adherence and Non-Persistence Should be Analyzed Separately- The Example of Methotrexate (Mtx) Therapy in the Therapy of Newly Treated Rheumatoid Arthritis in Germany

    Nov 1, 2015, 00:00

  • A Cost-Effective Analysis of The Optimum Number of Blood Culture for Adult Patients With Infection

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Hospital Pharmacist Review in Older Patients

    Nov 1, 2015, 00:00

  • Modeling The Natural History of Secondary-Progressive Multiple Sclerosis- A New Modeling Approach Using Discrete Event Simulation

    Nov 1, 2015, 00:00

  • Type II Diabetes Prevalence, Hypoglycemia Episodes, and Hba1C Control In Brazil

    Nov 1, 2015, 00:00

  • Risk Equation For Alcohol Related Consequences

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom

    Nov 1, 2015, 00:00

  • Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Prostate Cancer

    Nov 1, 2015, 00:00

  • Orphan and Ultra-Orphan Technologies- European and Australian Payer Perceptions

    Nov 1, 2015, 00:00

  • Application of Simple Imputation Techniques for Missing Pairwise Contrasts from Multi-Arm Trials when Using Frequentist Network Meta Analysis

    Nov 1, 2015, 00:00

  • Alternatives To Winbugs for Network Meta–Analysis

    Nov 1, 2015, 00:00

  • Cholera Death Audit In Ghana- A Medical Record Review of The 2014 Outbreak

    Nov 1, 2015, 00:00

  • Adapting Literature-Based Remission Rates for Chronic Spontaneous/Idiopathic Urticaria to The Needs of A Health Economic Model- A Kaplan-Meier Approach

    Nov 1, 2015, 00:00

  • Review of Policies And Perspectives on Real-World Data for Drug Development and Assessment (Imi-Getreal Deliverable)

    Nov 1, 2015, 00:00

  • Valuation of the Eq-5d-5l with Composite Time Trade-off for the German Population

    Nov 1, 2015, 00:00

  • Willingness To Pay For Improved Clinical Outcomes And Reduced Treatment Burden Associated With Insulin Treatment In People With Type 2 Diabetes In South America

    Nov 1, 2015, 00:00

  • Epidemiological Data Used In Rotavirus Vaccination Cost-Effectiveness Analysis In Europe- A Literature Review Update

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Everolimus Immunosupressive Therapy After Renal Transplantation

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Certolizumab Pegol for the Treatment of Active Psoriatic Arthritis in GREECE

    Nov 1, 2015, 00:00

  • Systematic Litertaure Review Of Direct Health Care Costs For Cardiovascular Events Among European Patients With Dyslipidemia Or High Cardiovascular Risk

    Nov 1, 2015, 00:00

  • Calculating The Prevalence of Urea Cycle Disorders In The Eu5 Using An Incidence–Survival Model

    Nov 1, 2015, 00:00

  • Population Cost-Effectiveness of a Parenting Program for the Treatment of Conduct Disorders- a Modelling Study to Assist Priority Setting in Australia

    Nov 1, 2015, 00:00

  • Prevalence and Incidence of Malnutrition Among Geriatrics Population in Turkey

    Nov 1, 2015, 00:00

  • Results Of A Dutch Cost-Effectiveness Model Of Radium-223 In Comparison To Cabazitaxel, Abiraterone, And Enzalutamide In Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Docetaxel

    Nov 1, 2015, 00:00

  • A New Pace for the Smc?

    Nov 1, 2015, 00:00

  • Revisiting The Simulation Evidence for the Incremental Cost-Effectiveness of Breast Cancer Screening of Average-Risk Women

    Nov 1, 2015, 00:00

  • Hrqol And Utility In Nocturia Are Correlated To Number Of Voids

    Nov 1, 2015, 00:00

  • Examining The Economic Impact of Laboratory Developed Testing In Flow Cytometry Immunophenotyping for Hematologic Malignancies- An Analysis of Health Resource Utilization

    Nov 1, 2015, 00:00

  • Cost – Effectiveness Analysis Of Budesonid Easyhaler In The Treatment Of Asthma In Children In The Russian Federation

    Nov 1, 2015, 00:00

  • The Potential Societal Cost Benefits Of Increasing Patient Satisfaction By Using An Inhaler With Improved Features Compared To Spiriva® Handihaler® For The Management Of Chronic Obstructive Pulmonary Disease (Copd) In The Uk

    Nov 1, 2015, 00:00

  • Utilizacion De Servicios De Salud Para El Tratamiento De Cáncer De Estomago En Venezuela

    Nov 1, 2015, 00:00

  • How Useful are Eq-5d And Zbi In Assessing The Impact of Caring for Alzheimer’s Disease Patients?

    Nov 1, 2015, 00:00

  • Expert Perspective on The Treatment of Functional Dyspepsia And Motility Disorders- A Multi-Criteria Decision Analysis Using The Analytic Hierarchy Process (Ahp)

    Nov 1, 2015, 00:00

  • The Contribution of Informal Caregiver Burden to Hta In Hematological Cancers In France, Germany, and The Us

    Nov 1, 2015, 00:00

  • The cancer drugs fund in england – undermining nice or efficient and good value for money?

    Nov 1, 2015, 00:00

  • Overall Survival (Os) And Quality-Of-Life (Qol) Outcomes In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck (Scchn)- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Delayed Enhancement Cardiac Magnetic Resonance to Refine Patient Selection For Implantable Cardioverter Defibrillator Therapy In Primary Prevention - An Exploratory Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Compression Therapy Of Venous Insufficiency. Cost And Quantity Characteristics Of Medical Devices In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • Examining Prescribing Patterns in Older Patients with Acute Illness

    Nov 1, 2015, 00:00

  • Systematic Review of Compliance to Bisphosphonates in Patients with Osteoporosis in Rct and Real Practice

    Nov 1, 2015, 00:00

  • Gasto de Bolsillo en Salud y Medicamentos en Chile- Análisis Comparativo de Los Periodos 1997, 2007 y 2012

    Nov 1, 2015, 00:00

  • Incremental Quality Adjusted Life Years (Qaly) Analysis in Absence of Head to Head and Health Related Quality of Life (Hrqol) Data- a Case Study in Thyroid Cancer

    Nov 1, 2015, 00:00

  • Clinical Characteristics, Lipid Treatment and Goal Attainment in a Familial Hypercholesterolemia Cohort in The Netherlands- a Cross Sectional Study

    Nov 1, 2015, 00:00

  • Development Of A Conceptual Model For Early Health Technology Assessment Of Tissue-Engineered Heart Valves

    Nov 1, 2015, 00:00

  • Effectiveness of The Antibiotic-Impregnated Catheters In Ventricular Drainage In Hydrocephalus Patients – A Systematic Review

    Nov 1, 2015, 00:00

  • A Mixed Methods Study of Researchers’ Experiences of Developing Core Outcome Sets

    Nov 1, 2015, 00:00

  • The Impact of Social Networks on The Students Health

    Nov 1, 2015, 00:00

  • Relationship Between Community Pharmacy Attribution And Patient’s Outcomes In Healthcare Service of Home-Visiting

    Nov 1, 2015, 00:00

  • Analysis of Health Services Utilization among Elderly in Slovenia

    Nov 1, 2015, 00:00

  • Examining The Sociological Influences on Physician Prescribing Behavior of Type 2 Diabetic Medications In Us Outpatient Setting

    Nov 1, 2015, 00:00

  • Pharmacoeconomics Of Ruxolitinib Therapy In Patients With Myelofibrosis

    Nov 1, 2015, 00:00

  • A Conceptual Search Filter to Identify Real-World Evidence

    Nov 1, 2015, 00:00

  • The Use of Propensity Score Matching Does Not Protect Against Regression Artifacts (Regression Towards The Mean)

    Nov 1, 2015, 00:00

  • Health State Utilities for Gaucher Disease Type 1

    Nov 1, 2015, 00:00

  • Understanding The Inter-Relationship Between Improved Glycaemic Control, Hypoglycaemia and Weight Change Within A Type 1 Diabetic Population

    Nov 1, 2015, 00:00

  • Retrospective Cohort Study Using Data From The Uk Clinical Practice Research Datalink and Hospital Episode Statistics to Assess Unplanned Hospitalisation In Patients With Multiple Myeloma

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Patients Aged 65-84 Years With Co-Morbidities or Immunosuppression In Belgium

    Nov 1, 2015, 00:00

  • Analysis of The Consumption And Pharmacoeconomic Evaluation of Using Different Formulations of Alpha-Lipoic Acid In The Pharmaceutical Market of Ukraine

    Nov 1, 2015, 00:00

  • Cost-Effectiveness In The Second-Line Treatment Of Non-Small Cell Lung Cancer (Nsclc) In The Us

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Different Strategies of Replacement Therapy In Russian Patients With Pancreatic Exocrine Insufficiency

    Nov 1, 2015, 00:00

  • An Economic Evaluation to Assess the Cost Effectiveness of the New Medicine Service in Improving Adherence in People Initiated on New Treatment for Gout

    Nov 1, 2015, 00:00

  • How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models

    Nov 1, 2015, 00:00

  • The Effectiveness and Cost-Effectiveness of Hylan G-F 20 in Osteoarthritis of the Knee

    Nov 1, 2015, 00:00

  • Examining the Economic Burden and Health Care Utilization of Menopausal Women in the U.S. Medicaid Population

    Nov 1, 2015, 00:00

  • Standards Of Surgical Materials Usage In Anterior Cruciate Ligament (Acl) Surgery In Brazil Under The Perspective Of The Private Health Care System

    Nov 1, 2015, 00:00

  • The Economic Impact Of Shape Formula For The Children Of Overweight And Obese Mothers

    Nov 1, 2015, 00:00

  • Patient-Centered Reasons for Primary Non-Adherence as Derived from the Peer-Reviewed Literature

    Nov 1, 2015, 00:00

  • Real-World Treatment Patterns of Ranibizumab Among Patients With Retinal Diseases In Canada- 5 Years Of Data

    Nov 1, 2015, 00:00

  • Implementation of Population Dynamics In Modelling Health And Budget Impact of An Intervention for A Chronic Disease With Multiple Disease Subtypes

    Nov 1, 2015, 00:00

  • Knowledge And Awareness Of Breast Cancer Among Young Women Living In South India

    Nov 1, 2015, 00:00

  • Adverse Events Costs Associated With Erlotinib Or Afatinib In Non-Small Cell Lung Cancer (Nsclc) Patients With Egfr Mutation-Positive Tumours

    Nov 1, 2015, 00:00

  • Does China’s New Medical Reform Improve Health Equity Of Rural Residents? Evidence From Household Surveys Before And After The Implementation Of New Medical Reform In Shaanxi Province, China

    Nov 1, 2015, 00:00

  • Cost Analysis of The Chronic Hcv-Related Cirrhosis In Bulgaria

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness of Referring Patients With Irritable Bowel Syndrome To A Gastroenterologist In The Uk

    Nov 1, 2015, 00:00

  • A Prospective Prescription Cost Analysis of Asthma Medication

    Nov 1, 2015, 00:00

  • Exploring the Use of Value of Information Methods to Prioritise Research to Address the Treatment Uncertainties Identified By the James Lind Alliance Priority Setting Partnerships

    Nov 1, 2015, 00:00

  • Medical Device Reimbursement Rules In Turkey- With Past And Current Practices, Looking Forward

    Nov 1, 2015, 00:00

  • Study on Cost-Effectiveness Analysis for Treatment of Major Depression Disease- a Systematic Review of Literature From 2004-2014

    Nov 1, 2015, 00:00

  • The Value Of Progression-Free Survival (Pfs) As An Endpoint In Oncology Trials

    Nov 1, 2015, 00:00

  • Prevalence Of Sleeping Pills Consumption And Its Association With Depressive Symptoms

    Nov 1, 2015, 00:00

  • Willing to Provide Medication Analysis? Predicting Pharmacists’ Intention to Provide Medication Analysis In Community Pharmacies In Germany

    Nov 1, 2015, 00:00

  • Evaluating the Cost-Effectiveness of GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the UK

    Nov 1, 2015, 00:00

  • Literature Review Of Economic Evaluations Of Screening Tests For Breast Cancer

    Nov 1, 2015, 00:00

  • Controlling the Cost Spent on Expensive Biologic Agents- an Example of Net Monetary Savings By Dose Optimisation of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Patients

    Nov 1, 2015, 00:00

  • Laparoscopic Surgery Versus Traditional Open Surgery For Kidney Implantation- A Cost-Effectiveness Model

    Nov 1, 2015, 00:00

  • Budget-Impact-Analysis Of Iron Treatment Using Intravenous Ferric Carboxymaltose In Patients With Chronic Heart Failure And Iron Deficiency In Austria

    Nov 1, 2015, 00:00

  • Economic Evaluation of Tocilizumab Combination in the Treatment of the patients with Dmard-Ir Rheumatoid Arthritis in China

    Nov 1, 2015, 00:00

  • Estimating the Impacts of Medication Adherence and Persistence on Costs and Hospitalization- the Case of Atypical Antipsychotics

    Nov 1, 2015, 00:00

  • Testing for Ns5a Resistance in Order to Optimize Antiviral Therapy With Simeprevir And Sofosbuvir 12 Weeks Appears Cost-Effective in Non-Cirrhotic Genotype 1 Hepatitis C Virus Treatment Experienced Patients

    Nov 1, 2015, 00:00

  • The Research on The Incidence of Kashin-Beck Disease and The Selenium Level In Children of Xunyi County

    Nov 1, 2015, 00:00

  • Patient Behaviour As A Cost Driver In The Management of Chronic Disease Patients

    Nov 1, 2015, 00:00

  • A Quantitative Analysis of Ten Health Technology Assessment (Hta) Agencies for Attributes Driving Transparency of the Organization

    Nov 1, 2015, 00:00

  • Organs-On-Chips- Exploring The Utility Of Biosynthesised Organ Tissue To Improve Efficiency Of The Drug Development Process

    Nov 1, 2015, 00:00

  • Local Cost Study Of Treatment Of Venous Thromboembolism In Turkey

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of the Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors – Nilotinib in the First and Second Lines of Therapy

    Nov 1, 2015, 00:00

  • Contraception Patterns In Brazil- 2012 National Survey Data

    Nov 1, 2015, 00:00

  • What Makes A Pharmaceutical Pricing Reimbursement Process Patient-Centric? A Comparative Analysis Of 11 Systems

    Nov 1, 2015, 00:00

  • Análisis De Costo Efectividad Y Costo Utilidad De La Adición De Rivaroxabán En El Tratamiento De Pacientes Con Síndrome Coronario Agudo En Colombia

    Nov 1, 2015, 00:00

  • Overall Survival (Os), Quality Of Life (Qol), And Neurocognitive Function (Nf) In Recurrent Glioblastoma Multiforme (Gbm)- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • 36 Months Pangaea- A 5-Year Non-Interventional Study of Safety, Efficacy and Pharmacoeconomic Data for Fingolimod Patients In Daily Clinical Practice

    Nov 1, 2015, 00:00

  • Public Consultations- A Tool for the Inclusion of Society in the Brazilian Hta Process

    Nov 1, 2015, 00:00

  • Configuracion Espacial de La Vulnerabilidad Social de Inmigrantes Internacionales en Iquique 2002-2012 y Su Relacion Con La Localizacion de Red de Atencion Primaria de Salud

    Nov 1, 2015, 00:00

  • Price Structure Assessment of Selected Oncology Products in China, Taiwan, South Korea, Brazil, and Mexico

    Nov 1, 2015, 00:00

  • Jósa András Hospital Complex Project - Cost-Benefit Analysis Of The Major Project Investment

    Nov 1, 2015, 00:00

  • Idiopathic Pulmonary Fibrosis- Hospital Disease Management and Associated Costs

    Nov 1, 2015, 00:00

  • The Ups And Downs Of Hpv-Related Cancers- Trends 2005-2014

    Nov 1, 2015, 00:00

  • The Intertemporal Changes Of Health Services Utilization During The Last Decade- The Case Of Austerity Inflicted On Greece

    Nov 1, 2015, 00:00

  • The Effect Of A Telephone Counseling Intervention By Pharmacist On Patients’ Beliefs About Medicines And Blood Pressure Control

    Nov 1, 2015, 00:00

  • Forecasting The Prevalence of Status Epilepticus and Its Subtypes In Europe, 2015–2024

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In United Kingdom

    Nov 1, 2015, 00:00

  • Trends of Implementation of Hta In Kazakhstan

    Nov 1, 2015, 00:00

  • Real World Evidence And Costs Of Chronic Heart Failure- Findings From 41,413 Patients Of The Arno Database

    Nov 1, 2015, 00:00

  • Health Economics And Radium-223 (Xofigo®) In The Treatment Of Metastatic Castration-Resistant Prostate Cancer (Mcrpc). A Case History And A Systematic Review Of The Literature On Cost-Effectiveness Analysis (Cea)

    Nov 1, 2015, 00:00

  • Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients?

    Nov 1, 2015, 00:00

  • Using Machine Learning to Detect Patients With Undiagnosed Rare Diseases- An Application of Support Vector Machines to A Rare Oncology Disease

    Nov 1, 2015, 00:00

  • An Overview of Reviews of The Clinical Effectiveness of Generic Chronic Disease Self Management Support Interventions

    Nov 1, 2015, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98 (current)
  • 99
  • 100
  • »